Chimerix (NASDAQ: CMRX) reported Q4 EPS of ($0.82), $0.08 worse than the analyst estimate of ($0.74). Revenue for the quarter came in at $3.1 million versus the consensus estimate of $2.86 million.

For earnings history and earnings-related data on Chimerix (CMRX) click here.